Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Comparative Randomized, Investigator-Blind, Active-Controlled, Parallel-Group, Multicenter, Clinical Endpoint Study to Evaluate Efficacy and Safety of Bimatoprost Ophthalmic Solution 0.01% (YSBP) of YS Life Science Co., Ltd. (YSLS) and Lumigan® (Bimatoprost Ophthalmic Solution) 0.01% of AbbVie INC, in the Treatment of Subjects With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH).
This study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. comp…
Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OH)
Estimated
~$10 – $8,750
YS Life Science Co., Ltd.NCT07661329
Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Open Angle Glaucoma (OAG)Ocular Hypertension (OH)
Estimated
~$10 – $1,050
Glaukos CorporationNCT07400926